Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2025-12-25 @ 4:45 PM
NCT ID: NCT03597503
Description: Adverse events reporting pertains to the Safety Population, defined as all subjects who received at least 1 dose of study drug and had at least one post-baseline safety assessment
Frequency Threshold: 5
Time Frame: Baseline/Visit 3 (Day 1) to Visit 8 (Day 46)-End of Study, a total of 46 days
Study: NCT03597503
Study Brief: Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Subjects treated with Placebo 0 None 0 20 8 20 View
Flexible Dose of SPN-810 Subjects treated with flexible dose of SPN-810 (36, 45 or 54 mg/day) 0 None 0 21 4 21 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.1) View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.1) View
Dystonia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.1) View
Lethargy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.1) View
Parkinsonism SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (18.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (18.1) View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (18.1) View
Conjunctivitis bacterial SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (18.1) View
Increased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (18.1) View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (18.1) View
Hand fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (18.1) View
Nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (18.1) View